4-((1R,3R)-1-(3,5-DIFLUOROFENIL)-3-(4-(3-ETIL-5-ISOPROPIL-4H-1,2,4-TRIAZOL-4-IL)PIPERIDIN-1-IL)BUTIL)-1-(METILSULFONIL)PIPERIDINA; SU PROCESO DE PREPARACION; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y SU USO EN EL TRATAMIENTO DE UNA

摘要

The present invention relates to 4-{(1R,3R)-1-(3,5-difluorophenyl)-3-[4-(3-ethyl-5-isopropyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl]butyl}-1-(methylsulfonyl)piperidine formula (I): or a pharmaceutically acceptable salt thereof, as well as to processes for preparing such a compound, to pharmaceutical compositions comprising such a compound and to the use of such a compound in the treatment of CCR5 mediated disease states.